Genetics of Type I Interferonopathy
Type I interferonopathies are conditions characterised by chronic upregulation of type I interferon signalling, driving systemic inflammation. A subset of Long COVID patients show interferon signature patterns suggesting interferonopathy-like pathology.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Type I Interferonopathy?
Type I interferonopathies are monogenic or polygenic conditions in which the type I interferon pathway is chronically activated — typically due to accumulation of nucleic acid species (from impaired DNA sensing regulation), mutations in interferon pathway brakes, or autoimmune mechanisms. They manifest as systemic lupus erythematosus-like conditions, chilblain lupus, or systemic inflammatory conditions. In Long COVID, elevated type I interferon signatures have been documented in a subset of patients, suggesting that post-COVID interferonopathy-like mechanisms may drive persistent inflammation in some cases.
Biological pathways commonly discussed in relation to Type I Interferonopathy
Research into Type I Interferonopathy and Chronic Interferon Activation has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Cgas Sting Chronic
The cGAS-STING pathway normally detects cytoplasmic DNA from pathogens or damaged cells. When chronically activated — due to impaired DNA clearance or gain-of-function STING variants — it drives constitutive interferon production.
Interferon Positive Feedback
Interferon signalling can create positive feedback loops where IFN-stimulated genes produce more interferon. Without adequate negative regulation (USP18, SOCS1), this can sustain chronic interferon activation.
Trex1 Dnase
TREX1 (DNase III) degrades cytoplasmic DNA, preventing cGAS activation. Loss-of-function TREX1 variants cause chilblain lupus and are associated with interferon signature elevation.
Ifn Signature
The interferon signature is a set of ISG transcripts upregulated by interferon. Its measurement distinguishes interferonopathies from other inflammatory conditions and has been used to characterise Long COVID subgroups.
Key genes studied in relation to Type I Interferonopathy
The following genes have been studied in relation to Type I Interferonopathy and Chronic Interferon Activation. These genes span the biological pathways most commonly discussed in this area of research.
18 genes total studied in relation to Type I Interferonopathy across the ChronicDNA dataset.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Type I Interferonopathy. Each variant represents a position in the genome where individuals may carry different alleles.
54 variants total across genes studied in relation to Type I Interferonopathy.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Type I Interferonopathy.
This is not a diagnostic service. Genetic variants do not determine whether you have Type I Interferonopathy, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Type I Interferonopathy shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
What is a type I interferonopathy?
Type I interferonopathies are conditions characterised by chronic upregulation of type I interferon signalling — either from genetic impairment of DNA clearance mechanisms, gain-of-function interferon pathway variants, or autoimmune triggers. They cause systemic inflammatory manifestations often resembling lupus.
Is Long COVID an interferonopathy?
Some Long COVID patients show elevated interferon signatures, suggesting interferonopathy-like mechanisms. Whether this represents a true interferonopathy or a secondary consequence of viral immune stimulation is still being investigated. Genetic predisposition to interferon pathway dysregulation may influence this subset.
What is the cGAS-STING pathway?
cGAS detects cytoplasmic DNA (from pathogens, damaged mitochondria, or cellular debris) and activates STING, which drives type I interferon production via IRF3. This pathway is a key innate immune sensor that, when chronically activated, drives interferonopathy-like inflammation.
Which genes are associated with type I interferonopathies?
Key genes include TREX1, IFIH1 (MDA5), TMEM173 (STING), USP18, ADAR1, SAMHD1, RNASEH2A/B/C, and DNASE1L3. Gain-of-function variants in these genes cause constitutive interferon pathway activation.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Type I Interferonopathy and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
18 genes · 54 variants analysed in relation to Type I Interferonopathy